These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of divalent cations on the interaction of platelets with tumor cells: aggregation and perfusion studies with two homologous human systems. Bastida E; Escolar G; Ordinas A; Giardina SL; Jamieson GA J Lab Clin Med; 1985 Jul; 106(1):68-74. PubMed ID: 4009024 [TBL] [Abstract][Full Text] [Related]
6. Studies on platelet functions in hirudin plasma. Glusa E; Urban U Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):88-93. PubMed ID: 2459038 [TBL] [Abstract][Full Text] [Related]
7. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets. Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439 [TBL] [Abstract][Full Text] [Related]
8. Indapamide inhibits human platelet aggregation in vitro: comparison with hydrochlorothiazide. Rendu F; Bachelot C; Molle D; Caen J; Guez D J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S57-63. PubMed ID: 7508063 [TBL] [Abstract][Full Text] [Related]
9. Concentration effects of platelets, fibrinogen and thrombin on platelet aggregation and fibrin clotting. Chao FC; Tullis JL; Kenney DM; Conneely GS; Doyle JR Thromb Diath Haemorrh; 1974 Sep; 32(1):216-31. PubMed ID: 4454041 [TBL] [Abstract][Full Text] [Related]
10. [Diphenylhydantoin induces an alteration in immune system cellular functions: an in vitro study of platelet and granulocyte aggregation]. Pasotti D; Mazzone A; Antoniello N; Ricevuti G Medicina (Firenze); 1990; 10(3):283-6. PubMed ID: 2079880 [TBL] [Abstract][Full Text] [Related]
11. Conditions influencing release of granule contents from human platelets in citrated plasma induced by ADP or the thrombin receptor activating peptide SFLLRN: direct measurement of percent release of beta-thromboglobulin and assessment by flow cytometry of P-selectin expression. Rand ML; Perry DW; Packham MA; Gemmell CH; Yeo EL; Kinlough-Rathbone RL Am J Hematol; 1996 Aug; 52(4):288-94. PubMed ID: 8701947 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat platelet aggregation by mycalolide-B, a novel inhibitor of actin polymerization with a different mechanism of action from cytochalasin-D. Sugidachi A; Ogawa T; Asai F; Saito S; Ozaki H; Fusetani N; Karaki H; Koike H Thromb Haemost; 1998 Mar; 79(3):614-9. PubMed ID: 9531051 [TBL] [Abstract][Full Text] [Related]
13. A new in vitro model for investigation of tumor cell-platelet-endothelial cell interactions and concomitant eicosanoid biosynthesis. Menter DG; Steinert BW; Sloane BF; Taylor JD; Honn KV Cancer Res; 1987 May; 47(9):2425-32. PubMed ID: 3552214 [TBL] [Abstract][Full Text] [Related]
14. [Mechanism of action of biogenic chloramines and hypochlorite on initial aggregation of blood platelets]. Murina MA; Savel'eva EL; Roshchupkin DI Biofizika; 2006; 51(2):299-305. PubMed ID: 16637337 [TBL] [Abstract][Full Text] [Related]
15. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591 [TBL] [Abstract][Full Text] [Related]
16. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF. Porta C; Maiolo A; Tua A; Grignani G Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928 [TBL] [Abstract][Full Text] [Related]
17. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes. Winocour PD; Kinlough-Rathbone RL; Mustard JF J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538 [TBL] [Abstract][Full Text] [Related]
18. Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents. Lages B; Weiss HJ Thromb Haemost; 1981 Apr; 45(2):173-9. PubMed ID: 6789496 [TBL] [Abstract][Full Text] [Related]
19. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. Shimoda K; Okamura S; Harada N; Kondo S; Okamura T; Niho Y J Clin Invest; 1993 Apr; 91(4):1310-3. PubMed ID: 7682568 [TBL] [Abstract][Full Text] [Related]
20. Thrombus formation and platelet-vessel wall interaction in the nephrotic syndrome under flow conditions. Zwaginga JJ; Koomans HA; Sixma JJ; Rabelink TJ J Clin Invest; 1994 Jan; 93(1):204-11. PubMed ID: 8282789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]